Latest filing published 21 Jun 2021 for BeiGene, Ltd.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Timothy Yung-Cheng Chen in BeOne Medicines Ltd., where the filings describe the role as board member. In total, 2 filings cover trades dated from 9 June 2021 to 16 June 2021.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 21 June 2021 with a share grant in BeOne Medicines Ltd. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations